Sign In
Buy SAVA
$1.96
+0 (+0%)
At Close: Jun 03, 2026
SAVA Stock Alert: Why Cassava Sciences Is Rocketing 50% Higher Today
01:26pm, Thursday, 04'th Nov 2021
Cassava Sciences just got good news. SAVA stock is soaring as the company celebrates the end of its manipulated data accusations.
Is it too risky to buy Cassava Sciences as Quintessential says the stock is worthless?
05:10pm, Wednesday, 03'rd Nov 2021
On Wednesday, Cassava Sciences Inc. (NASDAQ:SAVA) shares plunged more than 7% after Quintessential Capital management released a report saying the stock is worthless. The firm called for shorts to swo
Cassava Sciences Is on a Bumpy Road to Multibagger Status
03:08pm, Wednesday, 03'rd Nov 2021
Based on analyst estimates for the next ten years, SAVA stock could be worth three times more if its Alzheimer's drug succeeds. The post Cassava Sciences Is on a Bumpy Road to Multibagger Status appea
Cassava Sciences (SAVA) to Post Q3 Earnings: What's in Store?
01:03pm, Monday, 01'st Nov 2021
Investors will watch for updates on its lead candidate, sumifilam, for Alzheimer's disease in Cassava's (SAVA) Q3 earnings call.
Cassava Sciences Stock: Massive Potential Marred By Controversy
11:28am, Monday, 01'st Nov 2021
Cassava Sciences, Inc. is a pre-revenue biotechnology company. The company specializes in neurodegenerative diseases, such as Alzheimer's disease.
Cassava Sciences' Stock Remains an Enigma
06:00am, Monday, 01'st Nov 2021
Cassava Sciences has lost 26% for the month through Oct. 27. Entering October, SAVA stock looked to go on a big run.
Buy SAVA Stock on Dips as its Phase 3 Trial Moves Along
04:34pm, Friday, 29'th Oct 2021
There's no way to mitigate its high risk nature completely. But if you're bullish on Simulfilam?
Cassava Sciences: Welcome To The Casino
02:48pm, Monday, 25'th Oct 2021
There is a lot of hope with this one for those suffering from Alzheimer's.
3 Biotech Stocks That Are Ridiculously Overpriced
06:02am, Wednesday, 20'th Oct 2021
They've risen too far, too quickly.
New York, New York--(Newsfile Corp. - October 19, 2021) - The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders of Cassava Sciences, Inc. (NA
SAVA LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Cassava Sciences, Inc.
09:18am, Tuesday, 19'th Oct 2021
New York, New York--(Newsfile Corp. - October 19, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased Cassava Science
New York, New York--(Newsfile Corp. - October 19, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Cassava Sciences, Inc. (NASDAQ: SAVA) a
New York, New York--(Newsfile Corp. - October 18, 2021) - Pomerantz LLP announces that a class action lawsuit has been filed against Cassava Sciences, Inc. ("Cassava" or the "Company") (NASDAQ: SAVA)
SHAREHOLDER ALERT: SAVA WDH HNST: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
05:15pm, Monday, 18'th Oct 2021
NEW YORK, NY / ACCESSWIRE / October 18, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered
New York, New York--(Newsfile Corp. - October 18, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities
